{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:38:19Z","timestamp":1793824699958,"version":"4.6.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cell.2025.11.015","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:37:44Z","timestamp":1765294664000},"page":"872-886.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy"],"prefix":"10.1016","volume":"189","author":[{"given":"Yan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2025.11.015_bib1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2025.11.015_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.add9665","article-title":"The emerging era of cell engineering: Harnessing the modularity of cells to program complex biological function","volume":"378","author":"Lim","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.11.015_bib3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/acs.accounts.7b00526","article-title":"Leveraging engineering of cells for drug delivery","volume":"51","author":"Chen","year":"2018","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.cell.2025.11.015_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41551-021-00815-9","article-title":"Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2025.11.015_bib5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41551-021-00712-1","article-title":"Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets","volume":"5","author":"Hu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2025.11.015_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.015_bib7","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.cell.2021.02.048","article-title":"Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis","volume":"184","author":"Kaczanowska","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cell.2025.11.015_bib8","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41587-023-02118-7","article-title":"An oncolytic virus\u2013T cell chimera for cancer immunotherapy","volume":"42","author":"Chen","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2025.11.015_bib9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","article-title":"Engineering the next generation of cell-based therapeutics","volume":"21","author":"Bashor","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2025.11.015_bib10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41587-019-0137-8","article-title":"Gene editing for immune cell therapies","volume":"37","author":"Bailey","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2025.11.015_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature22395","article-title":"Therapeutic T cell engineering","volume":"545","author":"Sadelain","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.015_bib12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.11.015_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.add7034","article-title":"Probiotic-guided CAR-T cells for solid tumor targeting","volume":"382","author":"Vincent","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.11.015_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41417-018-0062-x","article-title":"Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors","volume":"27","author":"Golinelli","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.cell.2025.11.015_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2025.11.015_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41551-024-01195-6","article-title":"Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression","volume":"8","author":"Sirpilla","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2025.11.015_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41434-019-0074-7","article-title":"Delivering cellular and gene therapies to patients: solutions for realizing the potential of the next generation of medicine","volume":"27","author":"Elverum","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.cell.2025.11.015_bib18","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41551-024-01230-6","article-title":"Cell-drug conjugates","volume":"8","author":"Wang","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2025.11.015_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2025.11.015_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2025.11.015_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-021-00622-y","article-title":"Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases","volume":"22","author":"Kolkhir","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41586-023-06188-0","article-title":"Mast cells link immune sensing to antigen-avoidance behaviour","volume":"620","author":"Plum","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.015_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41586-023-06362-4","article-title":"Immune sensing of food allergens promotes avoidance behaviour","volume":"620","author":"Florsheim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.015_bib26","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.4049\/jimmunol.167.4.2298","article-title":"Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase","volume":"167","author":"Ishizuka","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib27","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.4049\/jimmunol.0904177","article-title":"The role of the CCL2\/CCR2 axis in mouse mast cell migration in vitro and in vivo","volume":"184","author":"Collington","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib28","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2004-11-4205","article-title":"IgE- and IgE+Ag-mediated mast cell migration in an autocrine\/paracrine fashion","volume":"105","author":"Kitaura","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.11.015_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.830199","article-title":"Harnessing the anti-tumor mediators in mast cells as a new strategy for adoptive cell transfer for cancer","volume":"12","author":"Fereydouni","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cell.2025.11.015_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fimmu.2019.00138","article-title":"Human mast cells from adipose tissue target and induce apoptosis of breast cancer cells","volume":"10","author":"Plotkin","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri1460","article-title":"Mast-cell responses to pathogens","volume":"4","author":"Marshall","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib33","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.4049\/jimmunol.1203420","article-title":"Innate immunity and its regulation by mast cells","volume":"190","author":"St John","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2025.11.015_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","article-title":"Clinical trial links oncolytic immunoactivation to survival in glioblastoma","volume":"623","author":"Ling","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.015_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2025.11.015_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/imr.12625","article-title":"Changing the threshold\u2014signals and mechanisms of mast cell priming","volume":"282","author":"Halova","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cell.2025.11.015_bib38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cell.2025.11.015_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13578-023-01144-x","article-title":"Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment","volume":"13","author":"Xie","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.cell.2025.11.015_bib40","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2024.05.001","article-title":"Distinct roles of TREM2 in central nervous system cancers and peripheral cancers","volume":"42","author":"Zhong","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2025.11.015_bib41","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/ijms22052458","article-title":"Genetic regulation of tryptase production and clinical impact: hereditary alpha tryptasemia, mastocytosis and beyond","volume":"22","author":"Sprinzl","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cell.2025.11.015_bib42","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1016\/j.cell.2023.11.001","article-title":"Choroid plexus mast cells drive tumor-associated hydrocephalus","volume":"186","author":"Li","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.cell.2025.11.015_bib43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-024-07906-y","article-title":"Engineered T cell therapy for central nervous system injury","volume":"634","author":"Gao","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.11.015_bib44","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ni971","article-title":"Mast cell\u2013dependent migration of effector CD8+ T cells through production of leukotriene B4","volume":"4","author":"Ott","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib45","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.11.015_bib46","article-title":"Two Rac1 pools integrate the direction and coordination of collective cell migration","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.11.015_bib47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tcb.2009.03.001","article-title":"Crosstalk between histone modifications during the DNA damage response","volume":"19","author":"van Attikum","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cell.2025.11.015_bib48","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ni1396","article-title":"RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development","volume":"7","author":"Gu","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib49","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2014.00569","article-title":"Mast cell mediators: their differential release and the secretory pathways involved","volume":"5","author":"Moon","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib50","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","article-title":"Antiviral neutralizing antibodies: from in vitro to in vivo activity","volume":"23","author":"Burton","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2025.11.015_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.omtm.2020.01.001","article-title":"Oncolytic viruses and the immune system: The dynamic duo","volume":"17","author":"Lemos de Matos","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.cell.2025.11.015_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41568-018-0009-4","article-title":"Oncolytic viruses as engineering platforms for combination immunotherapy","volume":"18","author":"Twumasi-Boateng","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2025.11.015_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41577-019-0271-z","article-title":"Immune crosstalk in cancer progression and metastatic spread: a complex conversation","volume":"20","author":"Garner","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2025.11.015_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17175-8","article-title":"Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma","volume":"11","author":"Hegde","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.11.015_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2023.04.013","article-title":"Tumor-infiltrating mast cells stimulate ICOS+ regulatory T cells through an IL-33 and IL-2 axis to promote gastric cancer progression","volume":"57","author":"Lv","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.cell.2025.11.015_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-57603-1","article-title":"Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell\u2013macrophage crosstalk through reprogramming glutamine metabolism in mice","volume":"16","author":"Wen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.11.015_bib58","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.abq6990","article-title":"The future of engineered immune cell therapies","volume":"378","author":"Irvine","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.11.015_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2025.11.015_bib60","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nbt.4181","article-title":"Enhancing T cell therapy through TCR-signaling\u2013responsive nanoparticle drug delivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat. Biotechnol."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009286742501311X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009286742501311X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:25:30Z","timestamp":1789705530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009286742501311X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S009286742501311X"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2025.11.015","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2025.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}